Research graph
References from Lung [ 18 F]FDG-PET is an early pharmacodynamic biomarker of antiviral efficacy in preclinical influenza. Local targets link to admitted publications; unresolved targets remain external evidence.
Global and national influenza-associated hospitalisation rates: Estimates for 40 countries and administrative regions
10.7189/jogh.13.04003 · 2023 · External reference
Global Respiratory Hospitalizations-Influenza Proportion Positive Working G. Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis
10.1371/journal.pmed.1003550 · 2021 · External reference
10.1093/aje/kwaa196
10.1093/aje/kwaa196 · External reference
The association between influenza infection and acute myocardial infarction: A comprehensive systematic review and meta-analysis
10.1016/j.virusres.2025.199594 · 2025 · External reference
Cardiac Characteristics of Hospitalized Influenza Patients: An Interim Analysis From the FluHeart Study
10.1111/irv.70067 · 2025 · External reference
10.3390/pathogens14030237
10.3390/pathogens14030237 · External reference
Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection
10.1186/cc10046 · 2011 · External reference
10.1186/s13054-019-2539-x
10.1186/s13054-019-2539-x · External reference
Surveillance of Hospitalized Cases of Severe Influenza in Catalonia Working G. Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype
10.1371/journal.pone.0210353 · 2019 · External reference
10.1111/irv.12470
10.1111/irv.12470 · External reference
10.1038/s41598-017-17497-6
10.1038/s41598-017-17497-6 · External reference
10.1128/cmr.00040-22
10.1128/cmr.00040-22 · External reference
10.1016/s0140-6736(24)01307-2
10.1016/s0140-6736(24)01307-2 · External reference
Antiviral Medications for Treatment of Nonsevere Influenza: A Systematic Review and Network Meta-Analysis
10.1001/jamainternmed.2024.7193 · 2025 · External reference
10.1016/j.lanwpc.2025.101651
10.1016/j.lanwpc.2025.101651 · External reference
10.1016/j.coviro.2014.04.009
10.1016/j.coviro.2014.04.009 · External reference
10.1001/jama.2025.25903
10.1001/jama.2025.25903 · External reference
10.2807/1560-7917.es.2025.30.49.2500894
10.2807/1560-7917.es.2025.30.49.2500894 · External reference
10.1016/j.cmi.2017.02.009
10.1016/j.cmi.2017.02.009 · External reference
10.1088/1752-7163/ac1a61
10.1088/1752-7163/ac1a61 · External reference
10.3390/antibiotics12010161
10.3390/antibiotics12010161 · External reference
10.1111/jcmm.16275
10.1111/jcmm.16275 · External reference
10.1007/s11307-017-1055-0
10.1007/s11307-017-1055-0 · External reference
10.1128/mbio.00317-19
10.1128/mbio.00317-19 · External reference
PET imaging of mycobacterial infection: transforming the pipeline for tuberculosis drug development
10.1038/s44303-025-00082-2 · 2025 · External reference
10.1172/jci.insight.93474
10.1172/jci.insight.93474 · External reference
10.1007/s00259-022-05892-9
10.1007/s00259-022-05892-9 · External reference
10.1093/infdis/jir663
10.1093/infdis/jir663 · External reference
18F-FDG PET imaging for identifying the dynamics of intestinal disease caused by SFTSV infection in a mouse model
10.18632/oncotarget.6645 · 2016 · External reference
10.1186/s13550-015-0143-x
10.1186/s13550-015-0143-x · External reference
10.1371/journal.ppat.1008903
10.1371/journal.ppat.1008903 · External reference
10.1371/journal.pone.0040094
10.1371/journal.pone.0040094 · External reference
Validation of Lung [18F]FDG Uptake as a Quantitative PET Biomarker for Influenza-Associated Pulmonary Inflammation
10.1007/s11307-025-02051-y · 2025 · External reference
Molecular imaging of viral pathogenesis and opportunities for the future
10.1038/s44303-024-00056-w · 2025 · External reference
Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance
10.4254/wjh.v7.i25.2590 · 2015 · External reference
10.1128/jvi.77.10.5933-5947.2003
10.1128/jvi.77.10.5933-5947.2003 · External reference
10.1002/hep.23985
10.1002/hep.23985 · External reference
10.1056/nejmoa1915341
10.1056/nejmoa1915341 · External reference
10.1371/journal.ppat.1010481
10.1371/journal.ppat.1010481 · External reference
10.2967/jnumed.125.269721
10.2967/jnumed.125.269721 · External reference
Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
10.1093/infdis/jiac135 · 2022 · External reference
10.1007/s00018-025-05611-1
10.1007/s00018-025-05611-1 · External reference
